These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 26034928)
1. Intermittent administration of parathyroid hormone improves the repairing process of rat calvaria defects: A histomorphometric and radiodensitometric study. Silva ED; Vasconcelos DF; Marques MR; Silva MA; Manzi FR; Barros SP Med Oral Patol Oral Cir Bucal; 2015 Jul; 20(4):e489-93. PubMed ID: 26034928 [TBL] [Abstract][Full Text] [Related]
2. The local administration of parathyroid hormone encourages the healing of bone defects in the rat calvaria: Micro-computed tomography, histological and histomorphometric evaluation. Auersvald CM; Santos FR; Nakano MM; Leoni GB; de Sousa Neto MD; Scariot R; Giovanini AF; Deliberador TM Arch Oral Biol; 2017 Jul; 79():14-19. PubMed ID: 28282513 [TBL] [Abstract][Full Text] [Related]
3. Intermittent parathyroid hormone treatment enhances guided bone regeneration in rat calvarial bone defects. Andreassen TT; Cacciafesta V J Craniofac Surg; 2004 May; 15(3):424-7; discussion 428-9. PubMed ID: 15111801 [TBL] [Abstract][Full Text] [Related]
4. Effects of parathyroid hormone dosage and schedule on bone regeneration. Tsunori K J Oral Sci; 2015 Jun; 57(2):131-6. PubMed ID: 26062862 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of Bone Augmentation in Osteoporotic Conditions by the Intermittent Parathyroid Hormone: An Animal Study in the Calvarium of Ovariectomized Rat. Kubota T; Hasuike A; Naito M; Tsunori K; Min S; Sato S Int J Oral Maxillofac Implants; 2018; 33(5):1003-1010. PubMed ID: 30231085 [TBL] [Abstract][Full Text] [Related]
6. Topical and intermittent application of parathyroid hormone recovers alveolar bone loss in rat experimental periodontitis. Tokunaga K; Seto H; Ohba H; Mihara C; Hama H; Horibe M; Yoneda S; Nagata T J Periodontal Res; 2011 Dec; 46(6):655-62. PubMed ID: 21722135 [TBL] [Abstract][Full Text] [Related]
7. Effects of intermittent administration of parathyroid hormone on bone augmentation in rat calvarium. Tsunori K; Sato S; Hasuike A; Manaka S; Shino H; Sato N; Kubota T; Arai Y; Ito K; Miyazaki M Implant Dent; 2015 Apr; 24(2):142-8. PubMed ID: 25706267 [TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone gene-activated matrix with DFDBA/collagen composite matrix enhances bone regeneration in rat calvarial bone defects. Lee PH; Yew TL; Lai YL; Lee SY; Chen HL J Chin Med Assoc; 2018 Aug; 81(8):699-707. PubMed ID: 29551486 [TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone (1-34) augments spinal fusion, fusion mass volume, and fusion mass quality in a rabbit spinal fusion model. O'Loughlin PF; Cunningham ME; Bukata SV; Tomin E; Poynton AR; Doty SB; Sama AA; Lane JM Spine (Phila Pa 1976); 2009 Jan; 34(2):121-30. PubMed ID: 19112335 [TBL] [Abstract][Full Text] [Related]
11. Bone healing with an in situ-formed bioresorbable polyethylene glycol hydrogel membrane in rabbit calvarial defects. Humber CC; Sándor GK; Davis JM; Peel SA; Brkovic BM; Kim YD; Holmes HI; Clokie CM Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):372-84. PubMed ID: 20060340 [TBL] [Abstract][Full Text] [Related]
12. An experimental study addressing the promotion of mandibular defect repair through the intermittent subcutaneous injection of parathyroid hormone. Tang ZL; Zhang WJ; Wang DX; Chen JM; Ma H; Wu DR J Oral Maxillofac Surg; 2014 Feb; 72(2):419-30. PubMed ID: 24071373 [TBL] [Abstract][Full Text] [Related]
13. Effect of bone morphogenetic protein-2, demineralized bone matrix and systemic parathyroid hormone (1-34) on local bone formation in a rat calvaria critical-size defect model. Stancoven BW; Lee J; Dixon DR; McPherson JC; Bisch FC; Wikesjö UM; Susin C J Periodontal Res; 2013 Apr; 48(2):243-51. PubMed ID: 22970744 [TBL] [Abstract][Full Text] [Related]
14. Effect of systemic parathyroid hormone (1-34) and a beta-tricalcium phosphate biomaterial on local bone formation in a critical-size rat calvarial defect model. Yun JI; Wikesjö UM; Borke JL; Bisch FC; Lewis JE; Herold RW; Swiec GD; Wood JC; McPherson JC J Clin Periodontol; 2010 May; 37(5):419-26. PubMed ID: 20236187 [TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of hyperbaric oxygen therapy with PTH [1-34] on calvarial bone graft in irradiated rat. Park KM; Hu KS; Choi H; Oh SE; Kim HI; Park W; Kim S Oral Dis; 2019 Apr; 25(3):822-830. PubMed ID: 30633848 [TBL] [Abstract][Full Text] [Related]
17. Effect of intermittent systemic administration of recombinant parathyroid hormone (1-34) on mandibular fracture healing in rats. Rowshan HH; Parham MA; Baur DA; McEntee RD; Cauley E; Carriere DT; Wood JC; Demsar WJ; Pizarro JM J Oral Maxillofac Surg; 2010 Feb; 68(2):260-7. PubMed ID: 20116693 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of parathyroid hormone bound to a synthetic matrix for guided bone regeneration around dental implants: a histomorphometric study in dogs. Valderrama P; Jung RE; Thoma DS; Jones AA; Cochran DL J Periodontol; 2010 May; 81(5):737-47. PubMed ID: 20429653 [TBL] [Abstract][Full Text] [Related]
19. [Effect of human PTH on steroid-induced osteopenia: a histomorphometric study of decalcified and undecalcified trabecular bone sections in rat]. Unoki E Nihon Seikeigeka Gakkai Zasshi; 1995 Oct; 69(10):1064-75. PubMed ID: 8551091 [TBL] [Abstract][Full Text] [Related]
20. Intermittent Administration of Parathyroid Hormone [1-34] Prevents Particle-Induced Periprosthetic Osteolysis in a Rat Model. Bi F; Shi Z; Zhou C; Liu A; Shen Y; Yan S PLoS One; 2015; 10(10):e0139793. PubMed ID: 26441073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]